News tagged with coronary events

Varying safety of add-on second-line T2DM treatments

(HealthDay)—For patients with type 2 diabetes who are taking metformin, the risk of cardiovascular events and mortality varies with the addition of different second-line therapies, according to a study published online ...

Jun 17, 2016
popularity3 comments 6

ELIXA trial shows CV safety of Lixisenatide

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...

Aug 31, 2015
popularity9 comments 0

Subscribe to rss feed